First Cryptocurrency on the Moon: Bitcoin, Solana, and Ethereum are now securely stored on the lunar surface using Iridia's ...

With over 550,000 U.S. patients requiring dialysis each year, ESRD treatment remains a major financial burden. March Kidney Month underscores the urgent need for cost-effective solutions like H.H.C.’s ...

USAHS furthers its commitment to the Austin community by offering accessible physical therapy screening services led by students and faculty.

NKGen Biotech, Inc. (“NKGen” or the “Company”) has regained compliance on its public reporting obligations with the filing of its most recent quarterly report on Form 10-Q on March 4, 2025; and ...

U.S. FDA approved Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the treatment of inflammatory lesions of rosacea in adults ...

The inducement grant consisted of time-based restricted stock units (“RSUs”) for 32,600 shares of Intellia’s common stock, with one-third of such RSUs vesting on March 1, 2026, 2027 and 2028.

Optime Care, a nationally recognized specialty pharmacy and an AscellaHealth Company, today announces an expanded partnership with Eton Pharmaceuticals (“Eton”), an innovative pharmaceutical company ...

Exclusive data access and expanded functionality allows trial sponsors and contract research organizations (CROs) to enhance inclusive representation, improve clinical trial enrollment, and strengthen ...

“This financing coupled with ongoing grant support strengthens our ability to rapidly advance our CNS cancer therapies,” said Marc H. Hedrick, M.D., Plus Therapeutics President and Chief Executive ...

OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today its financial results for the ...

The webcast of the fireside chat will be accessible in the investor section of 89bio’s website. A replay of the webcast will be available for approximately 30 days following the conference.

Leerink Global Biopharma Conference: Robert I. Blum, President and Chief Executive Officer, and Andrew Callos, Executive Vice President and Chief Commercial Officer, will participate in a fireside ...